📊 $4.04B raised across 25 deals | 6 sectors | Market sentiment: Mixed (52% negative reactions) | Guidance changes: 4 upgrades, 1 initial
Profit Guidance Updates
CVC Limited (CVC)
Major Upgrade
$0-0.6M NPAT
Market Cap: $245M 0.0% ●
$0-0.6M NPAT
Market Cap: $245M 0.0% ●
FY25 NPAT: $0-0.6M (major upgrade from $2.5M loss)
Previous Period: $2.5M loss (FY24)
Growth: Turnaround of up to $3.1M
Previous Period: $2.5M loss (FY24)
Growth: Turnaround of up to $3.1M
Key Drivers: Operational improvements and cost management initiatives
Standout Metric: Complete turnaround from $2.5M loss to potential $0.6M profit
WT Financial Group (WTL)
Upgrade
$5.4M NPBT
Market Cap: $44M 0.0% ●
$5.4M NPBT
Market Cap: $44M 0.0% ●
FY25 Underlying NPBT: $5.4M (upgraded from $4.5M)
Previous Period: $4.5M (FY24)
Growth: +$0.9M (+21.0%) vs previous year
Previous Period: $4.5M (FY24)
Growth: +$0.9M (+21.0%) vs previous year
Key Drivers: Strong revenue growth and reduced interest expense
Standout Metric: Revenue up 16.5% to $216.1M, NPBT growth of 21.0%
Briscoe Group Limited (BGP)
First Guidance
≥$29M NPAT
Market Cap: $1.21B +0.18% ●
≥$29M NPAT
Market Cap: $1.21B +0.18% ●
H1 FY25 NPAT: Not less than $29M (first guidance)
Q2 Group Sales: Up 2.07% to $192.9M
Environment: Tough economic conditions and subdued consumer sentiment
Q2 Group Sales: Up 2.07% to $192.9M
Environment: Tough economic conditions and subdued consumer sentiment
Key Drivers: Resilient performance despite challenging retail environment and consumer headwinds
Standout Metric: Maintaining profitability despite tough economic environment, Q2 sales growth of 2.07%
Tourism Holdings Limited (THL)
Reaffirm
$27.0M NPAT
Market Cap: $411M -1.33% ●
$27.0M NPAT
Market Cap: $411M -1.33% ●
FY25 Underlying NPAT: $27.0M (lower end of $27.0M-$34.4M range)
Takeover Bid: Rejected $2.30 per share from BGH
Board Valuation: "Well north of $3.00 per share"
Takeover Bid: Rejected $2.30 per share from BGH
Board Valuation: "Well north of $3.00 per share"
Key Drivers: Board believes share price reflected bottom-of-the-cycle trading environment
Standout Metric: Rejected takeover bid 30% below board valuation, confident in recovery prospects
Endeavour Group (EDV)
Initial Guidance
$420-425M NPAT
Market Cap: $7.24B -0.25% ●
$420-425M NPAT
Market Cap: $7.24B -0.25% ●
F25 Statutory NPAT: $420-425M (initial guidance)
Group F25 Sales: Expected $12.06 billion
Impact: One-off restructuring costs and Prowine bottling facility impairment
Group F25 Sales: Expected $12.06 billion
Impact: One-off restructuring costs and Prowine bottling facility impairment
Key Drivers: Strategy refresh underway, portfolio-wide examination of performance across Retail, Hotels and Pinnacle business
Standout Metric: Board undertaking comprehensive strategy refresh to maximize long-term shareholder value
Major Capital Raisings & M&A
WiseTech Global (WTC)
M&A
$3.15B
Market Cap: $38.93B -1.34% ●
$3.15B
Market Cap: $38.93B -1.34% ●
Target: E2open Parent Holdings Inc.
Financing: Fully debt funded via new syndicated facility
Price: $3.30/share cash
Financing: Fully debt funded via new syndicated facility
Price: $3.30/share cash
Use of Funds: Acquisition of e2open to expand into global trade/supply chain management
Key Metric: Largest deal of the week, 55th acquisition for WiseTech
PT Aneka Tambang (ATM)
Debt Facility
$769M AUD
Market Cap: $5.43B 0.0% ●
$769M AUD
Market Cap: $5.43B 0.0% ●
Facility Size: Up to US$500M
Structure: Term loan and revolving credit facility
Compliance: Material transaction under Indonesian regulations
Structure: Term loan and revolving credit facility
Compliance: Material transaction under Indonesian regulations
Use of Funds: Not specified
Key Metric: Largest debt facility of the week, requires regulatory compliance
Pacific Edge (PEB)
Placement + SPP
$20.7M
Market Cap: $69.01M -5.56% ●
$20.7M
Market Cap: $69.01M -5.56% ●
Target Amount: $20M
Issue Price: $0.10
Take-up Rate: 103.5% (oversubscribed)
Issue Price: $0.10
Take-up Rate: 103.5% (oversubscribed)
Conditions: Conditional on shareholder approval at AGM August 6
Key Metric: Exceeded target due to oversubscriptions, placement was upsized
Strategic Investments & Smaller Rounds
Nyrada Inc (NYR)
Biotech
$8.25M +1.37% ●
$8.25M +1.37% ●
Use: Phase IIa clinical trial for Xolatryp, drug manufacture, GMP
Lead: Canary Capital Pty Limited
Price: $0.30 (18.9% discount)
Lead: Canary Capital Pty Limited
Price: $0.30 (18.9% discount)
Firetail Resources (FTL)
Gold-Copper
$5.0M -2.33% ●
$5.0M -2.33% ●
Use: USA gold projects exploration, maiden drilling programs
Lead: Euroz Hartleys Limited
Status: Oversubscribed, tier-1 institutional investor participation
Lead: Euroz Hartleys Limited
Status: Oversubscribed, tier-1 institutional investor participation
Activeport Group (ATV)
Rights Issue
$2.5M +16.67% ●
$2.5M +16.67% ●
Structure: 1-for-2.75 non-renounceable, fully underwritten
Price: $0.01 (28.6% discount)
Standout: Significant positive price reaction, dramatic volume spike
Price: $0.01 (28.6% discount)
Standout: Significant positive price reaction, dramatic volume spike
Chilwa Minerals (CHW)
Heavy Minerals
$4.1M -2.73% ●
$4.1M -2.73% ●
Target: $4M (exceeded to $4.1M)
Price: $1.05 (5.4% discount)
Use: Accelerate Chilwa Project activities, exploration milestones
Price: $1.05 (5.4% discount)
Use: Accelerate Chilwa Project activities, exploration milestones
Thanks for reading Capital Signal